• 6 results in Exploration of Drug Science
    Sort by
    Latest
    Open Access
    Case Report
    Single or multiple treatments with lusutrombopag in subjects with thrombocytopenia and chronic liver disease needing an invasive procedure
    Thrombocytopenia is one of the most frequent implications of liver cirrhosis. This condition, when present in the severe form [platelet count (PLT) less than 50 × 109/L] correlates, with an increas [...] Read more.
    Davide Scalabrini ... Pietro Andreone
    Published: August 30, 2023 Explor Drug Sci. 2023;1:292–298
    DOI: https://doi.org/10.37349/eds.2023.00020
    This article belongs to the special issue Innovative Therapeutics in Hepato-Gastroenterology
    View:323
    Download:17
    Times Cited: 0
    Open Access
    Commentary
    Could flavonoid aglycones prevent the absorption of flavonoid glycosides by inhibiting sodium-dependent glucose transporter-1 in the small intestine?
    Flavonoids present a large group of natural polyphenols with numerous important health benefits for preventing and treating a diverse variety of pathological conditions. However, the actual therapeu [...] Read more.
    Katrin Sak
    Published: August 30, 2023 Explor Drug Sci. 2023;1:287–291
    DOI: https://doi.org/10.37349/eds.2023.00019
    This article belongs to the special issue Preventive and Therapeutic Potential of Nutraceuticals in Non-communicable Diseases
    View:309
    Download:15
    Times Cited: 0
    Open Access
    Original Article
    In silico study about β-amyloid’s role in Alzheimer’s disease and glaucoma and prediction of its interactions with glaucoma related proteins
    Aim: The significance of β-amyloid protein as a key player in neuro-degenerative disorders viz. Alzheimer’s disease (AD), Parkinson’s disease (PD) has been extensively researched and reporte [...] Read more.
    Nancy Maurya
    Published: August 29, 2023 Explor Drug Sci. 2023;1:276–286
    DOI: https://doi.org/10.37349/eds.2023.00018
    This article belongs to the special issue Machine Learning for Drug Science
    View:462
    Download:18
    Times Cited: 0
    Open Access
    Review
    Natural compounds from medicinal plants against COVID-19
    The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), known to cause the coronavirus disease 2019 (COVID-19), was declared a pandemic in early 2020. During the past time, several infecti [...] Read more.
    Anton Kolodnitsky ... Vladimir Poroikov
    Published: August 28, 2023 Explor Drug Sci. 2023;1:253–275
    DOI: https://doi.org/10.37349/eds.2023.00017
    This article belongs to the special issue Exploring Potential Drugs from Natural Products
    View:637
    Download:32
    Times Cited: 0
    Open Access
    Review
    Iron depletion in “metabolic fatty liver syndromes”: a strong biological rationale with disappointing liver outcomes
    Nonalcoholic fatty liver disease (NAFLD), its more rapidly progressive steatohepatitic variant [nonalcoholic steatohepatitis, (NASH)], and the recently defined metabolic dysfunction-associated fatty [...] Read more.
    Amedeo Lonardo
    Published: August 28, 2023 Explor Drug Sci. 2023;1:239–252
    DOI: https://doi.org/10.37349/eds.2023.00016
    This article belongs to the special issue Innovative Therapeutics in Hepato-Gastroenterology
    View:364
    Download:13
    Times Cited: 0
    Open Access
    Review
    The protective role of GLP-1 in neuro-ophthalmology
    Despite recent advancements in the field of neuro-ophthalmology, the rising rates of neurological and ophthalmological conditions, mismatches between supply and demand of clinicians, and an aging po [...] Read more.
    Sohum Sheth ... Brandon Lucke-Wold
    Published: August 28, 2023 Explor Drug Sci. 2023;1:221–238
    DOI: https://doi.org/10.37349/eds.2023.00015
    View:960
    Download:44
    Times Cited: 0